BioPortfolio Provides:

  • comprehensive market data
  • up to date reports
  • personal "find a report" service
  • reliable and quick

Contact us with your report needs NOW!

+44 1300 321501
priority@bioportfolio.com

BioPortfolio Specialist Market Reports:
Biotechnology, Life Science
Healthcare and Pharmaceutical
Market Research and Corporate Data

Search our store now...

Life Science market research and business reports

MediPoint: Craniomaxillofacial Devices - US Analysis and Market Forecasts…Craniomaxillofacial(CMF)surgeryihighlyspecializedbranchoforthopedicsurgerythatfocuseonallaspectoffacialandskulldisorderInGlobalDatcoverfollowingsegmentCMFplateandscrewfixationCMFdistractioncranialflapfixationtemporomandibularjoint(TMJ)replacementCMFbonegraftsubstituteandthoracicfixation(rigidfixationonly)ThroughoutadoptionpatternprocedurevolumeandmarketrevenueforallaforementionedsegmentareincludedInadditionGlobalDatincludedanalysionduralrepairmarketwhichconsistofduralsubstituteandduralsealantHoweverprocedurenumberandmarketrevenueforduralrepairareprovidedonlyforUmarketGlobalDatestimatethatDePuySynthecurrentlycontributetoabout34%ofUmarketforCMFdeviceFollowingDePuySyntheiStrykerBiometKLMartinandOsteoMedMovingforwardDePuySynthedominanceiwidelyconsiderednotreplicableduetoitlonghistoryinCMFfielditsignificantpresenceinorthopediccoremarketawellaitaggressivemarketingeffortBeyondthesemultinationalplayerrestofUCMFmarketioccupiedwithwiderangeofcompanieeitherfocusingonspecificsegmentsuchacranialflapfixationortargetinglow-endmarketwithme-tooproductScope-ofCMFwhichincludeepidemiologyetiologysymptomdiagnosipathologyandtreatmentguideline-AnnualizedUCMFmarketrevenueandfutureforecastfrom2011to2013forecastfor7yearto2020-InvestigationofcurrentandfuturemarketcompetitionforCMF-Insightfulreviewofkeyindustrydriverrestraintandchallengeawellapredictedimpactofkeyevent-Competitorassessmentincludingdeviceapprovalanalysianddevicesaleforecast-Marketedandpipelineproductprofilecoveringefficiencysafetystudydetaildeviceapprovalproductpositioninganddevicesaleforecast-Analysiofunmetneedwithinmarketandopportunitieforfutureplayer-Technologytrendevaluationtoassesstrengthofpipeline-ofalldeviceindevelopmentincludingstudydetaildesignandmaterialselectionconsiderationefficacyanddeviceapprovaltimeline-CompanyprofileincludingbusinesfinancialandSWOTanalysi-Coverageofkeymarketplayer-StrategicassessmentofCMFsectorthroughmarketimpactanalysifuturemarketscenarioandcompanyanalysi-DirectquotefromKeyOpinionLeader(KOL)awelladoctorReasontobuy-UnderstandtrendshapinganddrivingUCMFmarket-Realizedevicepreferenceofphysicianwhohaveperformedtestalready-AccesmarketsizingforecastandquantifiedgrowthopportunitieinUCMFmarketthrough2018-Quantifycandidatepatientpopulationtobetterdesignproductpricing&launchplan-Driverevenueformulateeffectivesaleandmarketingstrategieandgainin-depthunderstandingofcompetitivelandscape-Performbenchmarkinganalysiofgrowthopportunitieagainstcurrentlymarketedproduct-Assescompetitivenesofproductinmarketbyunderstandingstrengthandweaknesseofcurrentcompetition-Takecomprehensivelookatmarketdevicepipelineandidentifypromisingparadigm-shiftingproduct-Createeffectivecounter-strategytogaincompetitiveadvantageagainstthosecurrentlyinmarket-Organizeyoursaleandmarketingeffortbyidentifyingmarketcategorieandsegmentthatpresentbestopportunitieforgrowth-WhatnextbigthinginUCMFmarketlandscape?Identifyunderstandandcapitalize...read more

MediPoint: Craniomaxillofacial Devices - Current and Future Players…Craniomaxillofacial(CMF)surgeryihighlyspecializedbranchoforthopedicsurgerythatfocuseonallaspectoffacialandskulldisorderInGlobalDatcoverfollowingsegmentCMFplateandscrewfixationCMFdistractioncranialflapfixationtemporomandibularjoint(TMJ)replacementCMFbonegraftsubstituteandthoracicfixation(rigidfixationonly)ThroughoutadoptionpatternprocedurevolumeandmarketrevenueforallaforementionedsegmentareincludedInadditionGlobalDatincludedanalysionduralrepairmarketwhichconsistofduralsubstituteandduralsealantHoweverprocedurenumberandmarketrevenueforduralrepairareprovidedonlyforUmarketGivencurrentexigenteconomicconditionhospitaladministratoraredeployingdifferentapproachetorealizetheircost-containmentgoalMovingforwardalthoughcompetitionisettotighteningeneralorthopedicindustryduetoincreasedpricingerosionandausteritymeasureCMFmarketremainonethatpromisegrowthpotentialCurrentlyplateandscrewfixationimajorsegmentthatcompaniepayparticularattentiontoduetosteadyincreaseinprocedurevolumeofCMFtraumreconstructionandorthognathicsurgerieScope-InvestigationofcurrentandfuturemarketcompetitionforCraniomaxillofacialDevice-Competitorassessmentincludingdeviceapprovalanalysi-CoverageofkeymarketplayerandcompanyprofileincludingbusinesfinancialandSWOTanalysi-Strategicassessmentofdevicesectorthroughmarketimpactanalysifuturemarketscenarioandcompanyanalysi-DirectquotefromKeyOpinionLeader(KOL)awelladoctorusingCraniomaxillofacialDeviceinpracticeReasontobuy-GainhighlevelviewoftrendshapinganddrivingCraniomaxillofacialDevicemarket-Assescompetitivenesofproductinmarketbyunderstandingstrengthandweaknesseofcurrentcompetition-Driverevenueformulateeffectivesaleandmarketingstrategieandgainin-depthunderstandingofcompetitivelandscape-Takecomprehensivelookatmarketdevicepipelineandidentifypromisingparadigm-shiftingproduct-Createeffectivecounter-strategytogaincompetitiveadvantageagainstthosecurrentlyinmarket...read more

Vaginitis Global Clinical Trials Review, H2, 2014…GlobalDatdatonVaginitiscenarioelementalinformationanddatrelatingtoonVaginitiItincludeofnumberandtheirrecruitmentstatuapersiteofconductionacrosglobedatabookofferpreliminarycoverageofdiseasebytheirphasestatuprominenceofsponsorandalsobriefingpertainingtonumberofforkeydrugfortreatingVaginitiibuiltusingdatandinformationsourcedfromproprietarydatabaseprimaryandsecondaryresearchandin-houseanalysibyGlobalDatteamofindustryexpertNoteCertainsectioninmayberemovedoralteredbasedonavailabilityandrelevanceofdatforindicateddiseaseScope-DatonnumberofconductedinNorthAmericSouthandCentralAmericEuropeMiddle-EastandAfricandAsi-pacificandtopfivenationalcontributionineach-(completeandinprogres)datbyphasestatusubjectrecruitedandsponsortype-Listingofdiscontinued(suspendedwithdrawnandterminated)Reasontobuy-Understanddynamicofparticularindicationincondensedmanner-Abridgedviewofperformanceofintermoftheirstaturecruitmentlocationsponsortypeandmanymore-Obtaindiscontinuedlistingforacrosglobe-EspycommerciallandscapeofmajorUniversitie/Institute/HospitalorCompanie...read more

Trichuriasis Global Clinical Trials Review, H2, 2014…GlobalDatdatonTrichuriasiscenarioelementalinformationanddatrelatingtoonTrichuriasiItincludeofnumberandtheirrecruitmentstatuapersiteofconductionacrosglobedatabookofferpreliminarycoverageofdiseasebytheirphasestatuprominenceofsponsorandalsobriefingpertainingtonumberofforkeydrugfortreatingTrichuriasiibuiltusingdatandinformationsourcedfromproprietarydatabaseprimaryandsecondaryresearchandin-houseanalysibyGlobalDatteamofindustryexpertNoteCertainsectioninmayberemovedoralteredbasedonavailabilityandrelevanceofdatforindicateddiseaseScope-DatonnumberofconductedinNorthAmericSouthandCentralAmericEuropeMiddle-EastandAfricandAsi-pacificandtopfivenationalcontributionineach-(completeandinprogres)datbyphasestatusubjectrecruitedandsponsortype-Listingofdiscontinued(suspendedwithdrawnandterminated)Reasontobuy-Understanddynamicofparticularindicationincondensedmanner-Abridgedviewofperformanceofintermoftheirstaturecruitmentlocationsponsortypeandmanymore-Obtaindiscontinuedlistingforacrosglobe-EspycommerciallandscapeofmajorUniversitie/Institute/HospitalorCompanie...read more

Pyelonephritis Global Clinical Trials Review, H2, 2014…GlobalDatdatonPyelonephritiscenarioelementalinformationanddatrelatingtoonPyelonephritiItincludeofnumberandtheirrecruitmentstatuapersiteofconductionacrosglobedatabookofferpreliminarycoverageofdiseasebytheirphasestatuprominenceofsponsorandalsobriefingpertainingtonumberofforkeydrugfortreatingPyelonephritiibuiltusingdatandinformationsourcedfromproprietarydatabaseprimaryandsecondaryresearchandin-houseanalysibyGlobalDatteamofindustryexpertNoteCertainsectioninmayberemovedoralteredbasedonavailabilityandrelevanceofdatforindicateddiseaseScope-DatonnumberofconductedinNorthAmericSouthandCentralAmericEuropeMiddle-EastandAfricandAsi-pacificandtopfivenationalcontributionineach-(completeandinprogres)datbyphasestatusubjectrecruitedandsponsortype-Listingofdiscontinued(suspendedwithdrawnandterminated)Reasontobuy-Understanddynamicofparticularindicationincondensedmanner-Abridgedviewofperformanceofintermoftheirstaturecruitmentlocationsponsortypeandmanymore-Obtaindiscontinuedlistingforacrosglobe-EspycommerciallandscapeofmajorUniversitie/Institute/HospitalorCompanie...read more

Kaposi's Sarcoma Global Clinical Trials Review, H2, 2014…GlobalDatdatonKaposiSarcomscenarioelementalinformationanddatrelatingtoonKaposiSarcomItincludeofnumberandtheirrecruitmentstatuapersiteofconductionacrosglobedatabookofferpreliminarycoverageofdiseasebytheirphasestatuprominenceofsponsorandalsobriefingpertainingtonumberofforkeydrugfortreatingKaposiSarcomibuiltusingdatandinformationsourcedfromproprietarydatabaseprimaryandsecondaryresearchandin-houseanalysibyGlobalDatteamofindustryexpertNoteCertainsectioninmayberemovedoralteredbasedonavailabilityandrelevanceofdatforindicateddiseaseScope-DatonnumberofconductedinNorthAmericSouthandCentralAmericEuropeMiddle-EastandAfricandAsi-pacificandtopfivenationalcontributionineach-(completeandinprogres)datbyphasestatusubjectrecruitedandsponsortype-Listingofdiscontinued(suspendedwithdrawnandterminated)Reasontobuy-Understanddynamicofparticularindicationincondensedmanner-Abridgedviewofperformanceofintermoftheirstaturecruitmentlocationsponsortypeandmanymore-Obtaindiscontinuedlistingforacrosglobe-EspycommerciallandscapeofmajorUniversitie/Institute/HospitalorCompanie...read more

Malnutrition Global Clinical Trials Review, H2, 2014…GlobalDatdatonMalnutritionscenarioelementalinformationanddatrelatingtoonMalnutritionItincludeofnumberandtheirrecruitmentstatuapersiteofconductionacrosglobedatabookofferpreliminarycoverageofdiseasebytheirphasestatuprominenceofsponsorandalsobriefingpertainingtonumberofforkeydrugfortreatingMalnutritionibuiltusingdatandinformationsourcedfromproprietarydatabaseprimaryandsecondaryresearchandin-houseanalysibyGlobalDatteamofindustryexpertNoteCertainsectioninmayberemovedoralteredbasedonavailabilityandrelevanceofdatforindicateddiseaseScope-DatonnumberofconductedinNorthAmericSouthandCentralAmericEuropeMiddle-EastandAfricandAsi-pacificandtopfivenationalcontributionineach-(completeandinprogres)datbyphasestatusubjectrecruitedandsponsortype-Listingofdiscontinued(suspendedwithdrawnandterminated)Reasontobuy-Understanddynamicofparticularindicationincondensedmanner-Abridgedviewofperformanceofintermoftheirstaturecruitmentlocationsponsortypeandmanymore-Obtaindiscontinuedlistingforacrosglobe-EspycommerciallandscapeofmajorUniversitie/Institute/HospitalorCompanie...read more

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Africa…GlobalDatindustryanalysispecialisthareleaseditlatestiessentialsourceofinformationonandanalysiofhealthcareregulatoryandreimbursementlandscapeinSouthAfricItidentifiekeytrendincountryhealthcaremarketandinsightintoitdemographicregulatoryandreimbursementlandscapeandhealthcareinfrastructureMostimportantlyvaluableinsightintotrendandsegmentationofitpharmaceuticalandmedicaldevicemarketItusedatandinformationsourcedfromproprietarydatabasesecondaryresearchandin-houseanalysibyGlobalDatteamofindustryexpertpopulationofSouthAfricwaapproximately53millionin2013havinggrownatCompoundAnnualGrowthRate(CAGR)of17%from2008In2011governmentintroducedNationalHealthInsurance(NHI)schemealthoughitistillinearlystageofimplementationandinotexpectedtobefullyimplementeduntil2025In2013governmentspent$22billiononR&Dandexportedapproximately$1981mofpharmaceuticalmarketwaworthapproximately$25billionin2008andiprojectedtoreachapproximately$56billionby2020atCAGRof70%medicaldevicemarketwavaluedat$16billionin2008andiprojectedtogrowatCAGRof41%toestimated$26billionin2020Thesepositivegrowthtrendcbeprimarilyattributedto--increasinglyelderlypopulation-Governmentinitiative-DomesticbusinescompetitivenesScopeinformationonhealthcareregulatoryandreimbursementlandscapeinSouthAfricandinclude--ofpharmaceuticalandmedicaldevicemarketcomprisingmarketsizesegmentationandkeydriverandbarrier-ProfileandSWOTanalyseofmajorplayerinpharmaceuticalmarketAspenPharmacareAdcockIngramSanofiPfizerandRocheandprofileandSWOTanalyseofmajorplayerinmedicaldevicemarketSiemenHealthcareEssilorBBraunRocheCovidien-Insightfulreviewofreimbursementandregulatorylandscapewithanalysicoveringdetailofcountryhealthcarereimbursementprocesregulatoryagencieandapprovalprocessefornewdrugandmedicaldevice-Detailedanalysiofpoliticalandeconomicenvironmentcoveringeconomicindicatordemographichealthcareinfrastructureandhealthcareexpenditure-ofopportunitieforandchallengetogrowthinhealthcaremarketReasontobuywillenhanceyourdecision-makingcapabilitybyallowingyouto--DevelopbusinesstrategiebyunderstandingtrendshapinganddrivingSouthAfrichealthcaremarket-DriverevenuebyunderstandingkeytrendreimbursementandregulatorypoliciepharmaceuticalmarketsegmentandcompanielikelytoaffectSouthAfrichealthcaremarketinfuture-Formulateeffectivesaleandmarketingstrategiebyunderstandingcompetitivelandscapeandanalyzingperformanceofvarioucompetitor-Organizeyoursaleandmarketingeffortbyidentifyingmarketcategorieandsegmentthatpresentbestopportunitieforconsolidationinvestmentandstrategicpartnership-IdentifyunderstandandcapitalizeonopportunitieandchallengeinSouthAfrichealthcaremarket...read more

MediPoint: Nuclear Imaging - PET and SPECT Equipment - Global Analysis and Market Forecasts…examinehownewtechnologiecemergeinfaceofeconomicpressurethatmayaffectdemandfornuclearimagingandhowhealthcarereformareimpactingnuclearmedicineadventofhybridimaginghaenabledPET/CTimagingtoundergoexplosivegrowthHoweverhabeenatcostofincreaseddemandonstrugglinghealthcarebudgetPETandSPECTimagingarewellestablishedtechniquewithinnuclearimagingandaremainfocuofPETimagingusePositronEmittingradioactivetracerwithshorthalflifetoimagemetabolicallyactiveorganPETcombinedwithCTallowpreciseanatomicalimagingofbodyidentifyingdiseasedareadependingupontracerusedPET/CTimostoftenusedforcancerdiagnosiPET/MRIinewtechniquethatwaintroducedtoreducepatientexposuretoradiationPETonlysystemarenowgenerallyconsideredobsoleteduetosuperiorimagingqualityofPET/CTSPECTimaginguseGammEmittingradioactivetracerwithlongerhalflifetoimagemolecularprocesseinbodySPECTandSPECT/CTaremostoftenusedincardiologystudieSPECTandSPECT/CTmarketibiggermarketthPETPET/CTandPET/MRIbecauseinstrumenthavebeeninlongerusearecheaperandhavebecomecommontechniqueforwiderangeofindicationPhysicianbelievemoreandmoreSPECTprocedurewillbereplacedbyPETprocedureNewdevelopmentinhybridnuclearimagingpromisetofurtherincreaseutilityofhybridnuclearimagingwhilesignificantlyimprovingpatientcost-savingandsafetythroughreducedneedforrepeatexaminationfocuseoncurrentandfutureindustrytrendwithinnuclearmedicinemarketawelladiscussingpromisingpipelineproductandassessingcompetitivelandscapeHighlightKeyQuestionAnswered-Whaticurrentandfuturenuclearimagingmarketoutlookindevelopedandemergingmarket?WhattrendareaffectingglobalmarketforbothSPECTandPETimagingsystem?-Whicharekeyhighgrowthmarketthatmanufacturershouldseektoexpandinto?Whataretypeofproductthataremostlikelytosucceed?-HowmanyNuclearImagingProcedurearecarriedoutineachof10MajorMarket?Whatdoeimplyforinstrumentadoptionrate?-Whataremajorunmetneedinnuclearimaging?Inwhichareacmanufacturerhelpmeetthatneed?-Whatfactormostinfluencephysiciorhospitalinpurchaseofnewnuclearimagingequipment?Howmuchcphysiciinfluencepurchasingdecision?-HowwillreimbursementchangewillaffectnuclearimagingHowhaAffordableCareActaffectednuclearimaging?Howwillitaffectitinfuture?-Howwellarenewparadigminnuclearimagingperceived?Whatmotivatecompanietodevelopnewnuclearimagingmodalityphysicidemandorlegislativerequirement?KeyFinding-NuclearImagingimoderatelygrowingmarketwithCAGRof33%forperiodto2020-PET/CTSPECTSPECT/CTandScinitgraphyaremajortechniqueinnuclearimaging-Udominateworldmarketfornuclearimagingequipment-Uwillseelowestgrowthinnuclearimagingequipmentthanktoreimbursementpressure-JapandChinwillpresentgreatestopportunitieforgrowthwithrespectivemarketshareincreasingby75%andalmost100%duringforecastedperiod-BICnationwillexperiencehighestgrowthrateinnuclearimagingequipmentduringforecastperiod-Non-PETnuclearimagingprocedureindevelopedmarket(U5EUJap)likelyoveralltofallduringforecastperiodaresultofincreasingreimbursementpressureandnewtechnologie-PETimagingprocedureinallmarketlikelytoincreaseduringforecastperioddespitereimbursementpressureduetoincreasednumberofindicationScope-ofNuclearImagingincludingcoretechnologieestimatedproceduretrendanddisease-CurrentandFuturePlayerCompanieinvolvedinspacewithportfolioassessmentandSWOTanalysi-PipelineanalysiComprehensivedatsplitacrosdifferentstageofdevelopmentemergingtrendandnuclearimagingdeviceindevelopment-AnnualizedtotalnuclearimagingequipmentmarketrevenueforSPECTSPECT/CTPETPET/CTandPET/MRIandproceduredatfor2012-2013andforecastforsevenyearto2020-OtherKeytopiccoveredincludeidentificationofunmetneedimplicationfornuclearimagingmarketandhowtheymaybeovercomeinnearfuturereimbursementandregulatoryconsiderationevaluatingmarketaccesforeachregioncoveredin-AnalysiofmarketopportunitieinNuclearImagingmarketinadditiontoInsightfulreviewofkeyindustrydriverrestraintandchallengeEachtrendiindependentlyresearchedtoprovidequalitativeanalysiofitimplicationReasontobuy-Developanddesignyourin-licensingandout-licensingstrategiethroughreviewofpipelineproductandtechnologieandbyidentifyingcompaniewithmostrobustpipelineinfieldofPET/CTPET/MRIandSPECT/CT-Developbusinesstrategiebyunderstandingtrendshapinganddrivingnuclearimagingmarket-Driverevenuebyunderstandingkeytrendinnovativeproductandtechnologieandcompanielikelytoimpactnuclearimagingmarketinfuture-Formulateeffectivesaleandmarketingstrategiebyunderstandingcompetitivelandscapeandbyanalysingperformanceofvarioucompetitor-Identifyemergingplayerwithpotentiallystrongproductportfolioandcreateeffectivecounter-strategietogaincompetitiveadvantage-Trackdevicesaleinglobalandcountry-specificnuclearimagingmarketfrom2012-2020-Organizeyoursaleandmarketingeffortbyidentifyingmarketcategorieandsegmentthatpresentmaximumopportunitieforconsolidationinvestmentandstrategicpartnership...read more

Recordati S.p.A. - Product Pipeline Review - 2014…Recordati S.p.A. - Product Pipeline Review - 2014’, provides an overview of the Recordati S.p.A.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Recordati S.p.A.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA…...read more

Teijin Pharma Limited - Product Pipeline Review - 2014…Teijin Pharma Limited - Product Pipeline Review - 2014’, provides an overview of the Teijin Pharma Limited’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Teijin Pharma Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism…...read more

PharmaIN Corporation - Product Pipeline Review - 2014…PharmaIN Corporation - Product Pipeline Review - 2014’, provides an overview of the PharmaIN Corporation’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of PharmaIN Corporation’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA…...read more

ReGenX Biosciences, LLC - Product Pipeline Review - 2014…ReGenX Biosciences, LLC - Product Pipeline Review - 2014’, provides an overview of the ReGenX Biosciences, LLC’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of ReGenX Biosciences, LLC’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism…...read more

Piramal Enterprises Limited - Product Pipeline Review - 2014…Piramal Enterprises Limited - Product Pipeline Review - 2014’, provides an overview of the Piramal Enterprises Limited’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Piramal Enterprises Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism…...read more

Biosidus S.A. - Product Pipeline Review - 2014…Biosidus S.A. - Product Pipeline Review - 2014’, provides an overview of the Biosidus S.A.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Biosidus S.A.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA…...read more

Rodos BioTarget GmbH - Product Pipeline Review - 2014…Rodos BioTarget GmbH - Product Pipeline Review - 2014’, provides an overview of the Rodos BioTarget GmbH’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Rodos BioTarget GmbH’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism…...read more

RAPID Pharmaceuticals AG - Product Pipeline Review - 2014…RAPID Pharmaceuticals AG - Product Pipeline Review - 2014’, provides an overview of the RAPID Pharmaceuticals AG’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of RAPID Pharmaceuticals AG’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism…...read more

Phosphagenics Limited - Product Pipeline Review - 2014…Phosphagenics Limited - Product Pipeline Review - 2014’, provides an overview of the Phosphagenics Limited’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Phosphagenics Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA…...read more

Panmira Pharmaceuticals, LLC. - Product Pipeline Review - 2014…Panmira Pharmaceuticals, LLC. - Product Pipeline Review - 2014’, provides an overview of the Panmira Pharmaceuticals, LLC.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Panmira Pharmaceuticals, LLC.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism…...read more

OncoSec Medical Inc. - Product Pipeline Review - 2014…OncoSec Medical Inc. - Product Pipeline Review - 2014’, provides an overview of the OncoSec Medical Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of OncoSec Medical Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism…...read more

Kite Pharma, Inc. - Product Pipeline Review - 2014…Kite Pharma, Inc. - Product Pipeline Review - 2014’, provides an overview of the Kite Pharma, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Kite Pharma, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism…...read more

Immune Design Corp. - Product Pipeline Review - 2014…Immune Design Corp. - Product Pipeline Review - 2014’, provides an overview of the Immune Design Corp.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Immune Design Corp.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism…...read more

Grupo Ferrer Internacional, S.A. - Product Pipeline Review - 2014…Grupo Ferrer Internacional, S.A. - Product Pipeline Review - 2014’, provides an overview of the Grupo Ferrer Internacional, S.A.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Grupo Ferrer Internacional, S.A.’s, complete with comparative analysis at various stages, therapeutics assessment by…...read more

Cerecor Inc. - Product Pipeline Review - 2014…Cerecor Inc. - Product Pipeline Review - 2014’, provides an overview of the Cerecor Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Cerecor Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA…...read more

Blueprint Medicines - Product Pipeline Review - 2014…Blueprint Medicines - Product Pipeline Review - 2014’, provides an overview of the Blueprint Medicines’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Blueprint Medicines’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA…...read more

Easy Payment Options

We accept the following credit cards...
Visa Credit payments supported by WorldPayVisa Debit payments supported by WorldPayMastercard payments supported by WorldPayAmerican Express payments supported by WorldPayWorldPay Payments Processing

Or we can raise a pro forma invoice if you prefer.

Buy With Confidence

BioPortfolio has been selling market reports for over 16 years from the world's leading market research companies.

Personal Service

Our team will work with you to source the best report for your needs. We can liaise with publishers to obtain sample pages and negotiate discounts where available.

Market Leader

With over 15,000 visitors to our websites every day, BioPortfolio is the world's leading biotech, healthcare and medical resource online.